New research data surrounding the medication Retatrutide , specifically the 120mg formulation referred to as ZPHC, suggest a significant benefit on weight loss and linked metabolic factors. Scientists believe that this dual compound, influencing both GLP-1 and GIP pathways , has the potential to provide a major breakthrough in the approach of exce